Amarin Corp. (AMRN) – FDA
-
Amarin Corp. (AMRN) Reports New REDUCE-IT Data Showing VASCEPA Associated with 29 Percent Relative Risk Reduction Compared with Placebo
-
Amarin (AMRN) Provides Pricing & Reimbursement Updates for VAZKEPA in The Netherlands and Italy
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to AMRN Stock Lookup